A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...

Multiple sclerosis is a disease that results when the immune system mistakenly attacks the brain and spinal cord. It affects ...

Brittany Boudreau got a tattoo that reads “Somewhere weakness is our strength." It's now her motto for living with MS.

Tolebrutinib is more effective in reducing the risk of disability progression in MS patients with paramagnetic rim lesions, ...

For the first time, researchers have identified that inflammation—long associated with multiple sclerosis (MS)—appears to ...

A high-fish diet is linked to less MS disability progression over time, which could be explained by high levels of omega 3 ...

Research reveals how high salt intake disrupts regulatory T cells through specific gene activation, potentially increasing ...

Fully human intranasal foralumab shows promise in treating Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS.

Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who had a greater number of MRI paramagnetic rim lesions at baseline, data show ...

At the booming biotech campus of Pegasus Park in Dallas, up-and-coming biopharmaceutical company GenrAb believes it’s onto ...

Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative ...

Multiple sclerosis is a disease that results when the immune system mistakenly attacks the brain and spinal cord. It ...